News
Leo Lens Pharma Achieves Two Significant Milestones – FDA IND Submission and Seed Round Fundraising Success
November 12, 2020 | posted by Leo Lens
IND Paves the Way to Phase 2a Clinical Study and Seed Round Lead Advances Company’s Efforts for Its Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire, November 12th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the achievement […]
Leo Lens Pharma Expands Its Scientific Advisory Board
August 5, 2020 | posted by Leo Lens
External Thought Leaders to Help Guide Progress on Company’s Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire August 5th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the expansion of its Scientific Advisory Board (SAB) that now comprises […]
Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation
June 23, 2020 | posted by Leo Lens
Patented product for the novel treatment of glaucoma is IND-ready
Leo Lens Pharma Proud to Be Selected as a Connect 2020 Cool Company
May 29, 2020 | posted by Leo Lens
Leo Lens Pharma Appoints Dan Myers CEO
April 15, 2020 | posted by Leo Lens
Accomplished Ophthalmic Executive to Lead Company in Its Next Phase
Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma
February 20, 2020 | posted by Leo Lens
Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]
Biocom Member Spotlight: Interview with Kokila & Praful Doshi, Co-Founders of Leo Lens Technology
September 5, 2019 | posted by Leo Lens
Leo Lens was featured in a Member Spotlight article from Biocom. Read it here: https://www.biocom.org/corporate-newsletter/newsletter-article/?article=Biocom-Member-Spotlight-Interview-with-Kokila-and-Praful-Doshi-Co-Founders-of-Leo-Lens-Technology
Leo Lens Selected as Presenting Company at Octane MTIF 2018
October 10, 2018 | posted by Leo Lens
Leo Lens was selected from over 150 companies to be a presenting company at Octane’s 2018 Medical Technology Innovation Forum. For more information on the event go to www.mtif2018.com.
Associations
© 2018 Leo Lens Technology, Inc.